Anacor Pharmaceuticals Inc Share Price
Equities
US0324201013
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
2016 | Anacor Pharmaceuticals : received rival bid before Pfizer deal - filing | RE |
2016 | Anacor Pharmaceuticals : Pfizer to buy Anacor in $5.2 billion deal for access to eczema gel | RE |
Managers | Title | Age | Since |
---|---|---|---|
Douglas Giordano
CEO | Chief Executive Officer | 61 | 24/16/24 |
Chief Tech/Sci/R&D Officer | 77 | 01/04/01 | |
Director/Board Member | - | 24/16/24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Giordano
CEO | Chief Executive Officer | 61 | 24/16/24 |
Bryan Supran
BRD | Director/Board Member | - | 24/16/24 |
Director/Board Member | - | 24/16/24 |
1st Jan change | Capi. | |
---|---|---|
+21.85% | 4.8TCr | |
+0.67% | 4.24TCr | |
+43.96% | 4.15TCr | |
+26.33% | 3.16TCr | |
+20.72% | 2.86TCr | |
-4.47% | 2.8TCr | |
+52.06% | 1.46TCr | |
+44.54% | 1.41TCr | |
+2.63% | 1.26TCr |
- Stock Market
- Equities
- Stock